The SPDR ETF holds major pharmaceutical companies including Johnson & Johnson, Amgen, Eli Lilly, AbbVie, and Gilead Sciences.

The entities involved

• SPDR →

  family of exchange-traded funds (ETFs) managed by State Street Global Advisors

  • SPDR purchased shares of Super Micro Computer, Inc. following its inclusion in the S&P 500 index.Fri 00:06
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
  • Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
• Amgen →

  American multinational biopharmaceutical company

  • Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05

Related events

• Reports on the top holdings of various healthcare and biotech ETFs, listing major pharmaceutical companies like Eli Lilly, Amgen, and Johnson & Johnson.Sep 10
• An ETF holds shares of Johnson & Johnson, ExxonMobil, and JPMorgan Chase.Sep 15
• Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital.Jun 19